Cargando…

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

Metabolomics is increasingly being applied towards the identification of biomarkers for disease diagnosis, prognosis and risk prediction. Unfortunately among the many published metabolomic studies focusing on biomarker discovery, there is very little consistency and relatively little rigor in how re...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jianguo, Broadhurst, David I., Wilson, Michael, Wishart, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608878/
https://www.ncbi.nlm.nih.gov/pubmed/23543913
http://dx.doi.org/10.1007/s11306-012-0482-9
_version_ 1782264279069622272
author Xia, Jianguo
Broadhurst, David I.
Wilson, Michael
Wishart, David S.
author_facet Xia, Jianguo
Broadhurst, David I.
Wilson, Michael
Wishart, David S.
author_sort Xia, Jianguo
collection PubMed
description Metabolomics is increasingly being applied towards the identification of biomarkers for disease diagnosis, prognosis and risk prediction. Unfortunately among the many published metabolomic studies focusing on biomarker discovery, there is very little consistency and relatively little rigor in how researchers select, assess or report their candidate biomarkers. In particular, few studies report any measure of sensitivity, specificity, or provide receiver operator characteristic (ROC) curves with associated confidence intervals. Even fewer studies explicitly describe or release the biomarker model used to generate their ROC curves. This is surprising given that for biomarker studies in most other biomedical fields, ROC curve analysis is generally considered the standard method for performance assessment. Because the ultimate goal of biomarker discovery is the translation of those biomarkers to clinical practice, it is clear that the metabolomics community needs to start “speaking the same language” in terms of biomarker analysis and reporting-especially if it wants to see metabolite markers being routinely used in the clinic. In this tutorial, we will first introduce the concept of ROC curves and describe their use in single biomarker analysis for clinical chemistry. This includes the construction of ROC curves, understanding the meaning of area under ROC curves (AUC) and partial AUC, as well as the calculation of confidence intervals. The second part of the tutorial focuses on biomarker analyses within the context of metabolomics. This section describes different statistical and machine learning strategies that can be used to create multi-metabolite biomarker models and explains how these models can be assessed using ROC curves. In the third part of the tutorial we discuss common issues and potential pitfalls associated with different analysis methods and provide readers with a list of nine recommendations for biomarker analysis and reporting. To help readers test, visualize and explore the concepts presented in this tutorial, we also introduce a web-based tool called ROCCET (ROC Curve Explorer & Tester, http://www.roccet.ca). ROCCET was originally developed as a teaching aid but it can also serve as a training and testing resource to assist metabolomics researchers build biomarker models and conduct a range of common ROC curve analyses for biomarker studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-012-0482-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3608878
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-36088782013-03-28 Translational biomarker discovery in clinical metabolomics: an introductory tutorial Xia, Jianguo Broadhurst, David I. Wilson, Michael Wishart, David S. Metabolomics Review Article Metabolomics is increasingly being applied towards the identification of biomarkers for disease diagnosis, prognosis and risk prediction. Unfortunately among the many published metabolomic studies focusing on biomarker discovery, there is very little consistency and relatively little rigor in how researchers select, assess or report their candidate biomarkers. In particular, few studies report any measure of sensitivity, specificity, or provide receiver operator characteristic (ROC) curves with associated confidence intervals. Even fewer studies explicitly describe or release the biomarker model used to generate their ROC curves. This is surprising given that for biomarker studies in most other biomedical fields, ROC curve analysis is generally considered the standard method for performance assessment. Because the ultimate goal of biomarker discovery is the translation of those biomarkers to clinical practice, it is clear that the metabolomics community needs to start “speaking the same language” in terms of biomarker analysis and reporting-especially if it wants to see metabolite markers being routinely used in the clinic. In this tutorial, we will first introduce the concept of ROC curves and describe their use in single biomarker analysis for clinical chemistry. This includes the construction of ROC curves, understanding the meaning of area under ROC curves (AUC) and partial AUC, as well as the calculation of confidence intervals. The second part of the tutorial focuses on biomarker analyses within the context of metabolomics. This section describes different statistical and machine learning strategies that can be used to create multi-metabolite biomarker models and explains how these models can be assessed using ROC curves. In the third part of the tutorial we discuss common issues and potential pitfalls associated with different analysis methods and provide readers with a list of nine recommendations for biomarker analysis and reporting. To help readers test, visualize and explore the concepts presented in this tutorial, we also introduce a web-based tool called ROCCET (ROC Curve Explorer & Tester, http://www.roccet.ca). ROCCET was originally developed as a teaching aid but it can also serve as a training and testing resource to assist metabolomics researchers build biomarker models and conduct a range of common ROC curve analyses for biomarker studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-012-0482-9) contains supplementary material, which is available to authorized users. Springer US 2012-12-04 2013 /pmc/articles/PMC3608878/ /pubmed/23543913 http://dx.doi.org/10.1007/s11306-012-0482-9 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/2.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review Article
Xia, Jianguo
Broadhurst, David I.
Wilson, Michael
Wishart, David S.
Translational biomarker discovery in clinical metabolomics: an introductory tutorial
title Translational biomarker discovery in clinical metabolomics: an introductory tutorial
title_full Translational biomarker discovery in clinical metabolomics: an introductory tutorial
title_fullStr Translational biomarker discovery in clinical metabolomics: an introductory tutorial
title_full_unstemmed Translational biomarker discovery in clinical metabolomics: an introductory tutorial
title_short Translational biomarker discovery in clinical metabolomics: an introductory tutorial
title_sort translational biomarker discovery in clinical metabolomics: an introductory tutorial
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608878/
https://www.ncbi.nlm.nih.gov/pubmed/23543913
http://dx.doi.org/10.1007/s11306-012-0482-9
work_keys_str_mv AT xiajianguo translationalbiomarkerdiscoveryinclinicalmetabolomicsanintroductorytutorial
AT broadhurstdavidi translationalbiomarkerdiscoveryinclinicalmetabolomicsanintroductorytutorial
AT wilsonmichael translationalbiomarkerdiscoveryinclinicalmetabolomicsanintroductorytutorial
AT wishartdavids translationalbiomarkerdiscoveryinclinicalmetabolomicsanintroductorytutorial